Posts by suzy
U-NEURON’s ED Drug UA002 Validates Phase 1 Safety Profile
U-NEURON (6973), a biotech companylistedon Taiwan’s Emerging Stock Market, announced on the 3rd that Phase 1 clinical trial enrollment for its novel therapeutic UA002, targeting male erectile dysfunction (ED), has been completed, with Phase 2 trials set to commence.
i-ExoCraft® Platform: World’s First AI-Driven Exosome Design & Manufacturing Platform
The world's first AI-driven Exosome Design House platform for integrated exosome design and manufacturing. Tailored for multidimensional scenarios across aesthetics, skincare, and precision medicine, it analyzes miRNA and proteomic profiles for functional prediction, delivering evidence-based, patented, and differentiated products for clients.
New Deer Amniotic Fluid Stem Cell Exosome Skincare Series Enters China’s High-End Beauty Market
U-NEURON reaches a new operational milestone! The entry of its novel deer amniotic fluid stem cell exosome skincare line into Mainland China's premium beauty sector is set to propel this year's overall operational performance to new heights.
International Certification: Industry-Leading Number of Exosome INCI Registrations
Demonstrating international R&D capabilities, we have successfully obtained 6 exosome INCI (International Nomenclature of Cosmetic Ingredients) registrations covering multiple cell sources, including human AFSCs. We provide flexible and diverse ingredient formulation solutions to fully empower the innovative development of premium skincare products.